Regen BioPharma Inc (RGBP)

[Canadian Trader]

I just wanted to expand on your comment, CV, and add some background DD surrounding the HemaXellerate safety studies.

Back in July 2013, BMSN shared some efficacy data for HemaXellerate, which monitored white blood cell count over 14 days after bone marrow injury.

Based on experiments that FDA requested, the company generated new data further demonstrating efficacy of HemaXellerate I™ in animal models. This may be seen in the figure attached.

Efficacy Figure: http://www2.marketwire.com/mw/frame_mw?attachid=2370423

Link to the source PR: http://ih.advfn.com/p.php?pid=nmona&article=58628844

Now this is efficacy, not safety, so I'd have to imagine the safety study will look at a longer timeframe. I just wanted to share this to at least speculate on the fact that the estimated timeframe for the GLP study is likely only a matter of weeks/months from start to finish.

$ RGBP $